Under a hyperglycemic environment, ROS activates the NLRP3 inflammasome in β cells, elevating caspase-1-dependent IL-1β secretion; this mediates dysfunction of β-cell insulin secretion and promotes obesity and insulin resistance, finally leading to pyroptosis and the development of T2DM. The gene discussed is NLRP3; the disease is Insulin resistance.